5d 1m 3m 1y 5y 10y
There are no Transcripts on NVGN.
NVGN vs. ETF Alternatives
Novogen Ltd., is engaged in pharmaceutical drug development. It develops single drug capable of killing both the dominant differentiated cells in a cancer as well as the undifferentiated cancer stem cells at a therapeutic dose.